Apremilast
- ₹0
- Product name: Apremilast
- CAS: 608141-41-9
- MF: C22H24N2O7S
- MW: 460.5
- EINECS:807-237-6
- MDL Number:MFCD18782607
- Synonyms:(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide;ApreMilast,CC-10004;AcetaMide, N-[2-[(1S)-1-(3-ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-;(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide Apremilast (CC-10004;(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl);Apremilast (S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione;Appleton West;N-[2-[(1S)-1-(3ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
Melting point :152-156°C
Boiling point :741.3±60.0 °C(Predicted)
Density :1.381
storage temp. :Refrigerator
solubility :Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
pka :14.01±0.20(Predicted)
form :Solid
color :White to Pale Yellow
InChIKey :IMOZEMNVLZVGJZ-QGZVFWFLSA-N
SMILES :C(NC1=CC=CC2=C1C(=O)N([C@@H](C1=CC=C(OC)C(OCC)=C1)CS(C)(=O)=O)C2=O)(=O)C
CAS DataBase Reference :608141-41-9
Boiling point :741.3±60.0 °C(Predicted)
Density :1.381
storage temp. :Refrigerator
solubility :Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
pka :14.01±0.20(Predicted)
form :Solid
color :White to Pale Yellow
InChIKey :IMOZEMNVLZVGJZ-QGZVFWFLSA-N
SMILES :C(NC1=CC=CC2=C1C(=O)N([C@@H](C1=CC=C(OC)C(OCC)=C1)CS(C)(=O)=O)C2=O)(=O)C
CAS DataBase Reference :608141-41-9
Safety Information
Symbol(GHS): | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||
Precautionary statements: |
|
Description
Apremilast (Otezla) was approved by the FDA on March 21, 2014 for the treatment of adult patients with active psoriatic arthritis. Apremilast is a member of a new class of oral small molecule inhibitors of the phosphosphodiesterase 4 (PDE4) enzyme. When PDE4 is inhibited in immune cells, it results in elevation of intracellular cyclic adenosine monophosphate (cAMP) levels, which can regulate inflammatory mediators. The current clinical data indicate that apremilast is an effective and well tolerated option for the management of psoriasis and PsA in adults.More related product prices
918504-65-1 871700-17-3 182431-12-5 Nintedanib Avanafil Pazopanib 3-Ethoxy-4-Methoxy-alpha-[(Methylsulfonyl)Methyl]-benzeneMethanaMine (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine N-acetyl-L-leucine salt [[p-(2-methoxyethyl)phenoxy]methyl]oxirane 6296-53-3 ApreMilast-d5Related product price
- 182431-12-5
₹7500-69886.2 - Avanafil
₹3163.5-11888.1 - Pazopanib
₹7393.48-33730.7